Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chlorinated Naphthalene Poisoning.

British medical journal·2010
Same author

Diagnosis of Carcinoma.

Canadian Medical Association journal·2010
Same author

Autopsy Lung Cultures.

Canadian Medical Association journal·2010
Same author

The Definition of a Specialist.

Canadian Medical Association journal·2010
Same author

Alloxan diabetes: a discovery, albeit a minor one.

The journal of the Royal College of Physicians of Edinburgh·2002
Same author

Venereal disease vs Bowen's disease.

JAMA·1977

Related Experiment Video

Updated: Jul 9, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Alloxan diabetes: the sorcerer and his apprentice.

N G McLetchie

    Diabetologia
    |July 1, 1982
    PubMed
    Summary

    The discovery of alloxan diabetes resulted from an accidental observation during wartime research. An apprentice noted that alloxan administration in rabbits mimicked symptoms of hypoglycemia, leading to the development of alloxan-induced diabetes.

    Area of Science:

    • Endocrinology
    • Pathology
    • Nephrology

    Background:

    • J. Shaw Dunn's extensive research on kidney and reno-tubular necrosis.
    • McLetchie's burgeoning interest in endocrine research despite wartime challenges.
    • Colonel Sheehan's description of hypoglycemia linked to postpartum pituitary necrosis.

    Observation:

    • McLetchie observed that rabbits treated with alloxan exhibited behaviors mirroring hypoglycemia.
    • This observation occurred during research initially aimed at the Crush Kidney syndrome.
    • The parallel between alloxan's effect and Sheehan's description was a key insight.

    Findings:

    • The accidental administration of alloxan in rabbits led to the development of diabetes.
    • This serendipitous finding established alloxan as an inducer of experimental diabetes.

    More Related Videos

    Stabilizing a Femur Osteotomy with a Plate Fixation in Ambystoma mexicanum
    05:45

    Stabilizing a Femur Osteotomy with a Plate Fixation in Ambystoma mexicanum

    Published on: April 12, 2024

    Atomic Force Microscopy Measurements of Cartilage in Intact and Regenerating Axolotl Limbs
    09:19

    Atomic Force Microscopy Measurements of Cartilage in Intact and Regenerating Axolotl Limbs

    Published on: October 11, 2024

    Related Experiment Videos

    Last Updated: Jul 9, 2026

    Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
    10:30

    Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

    Published on: May 24, 2016

    Stabilizing a Femur Osteotomy with a Plate Fixation in Ambystoma mexicanum
    05:45

    Stabilizing a Femur Osteotomy with a Plate Fixation in Ambystoma mexicanum

    Published on: April 12, 2024

    Atomic Force Microscopy Measurements of Cartilage in Intact and Regenerating Axolotl Limbs
    09:19

    Atomic Force Microscopy Measurements of Cartilage in Intact and Regenerating Axolotl Limbs

    Published on: October 11, 2024

  • The discovery highlighted a connection between chemical agents and pancreatic islet cell damage.

    • Implications:

    • Established a novel method for inducing experimental diabetes in research settings.
    • Provided a tool for studying the pathogenesis of diabetes mellitus.
    • Contributed to the understanding of pancreatic beta-cell function and destruction.